Artificial Intelligence Tool Measures Mesothelioma Treatment Response
Scientists at the University of Glasgow in Scotland have developed an artificial intelligence tool that could revolutionize the way doctors plan and monitor mesothelioma treatment. The University team collaborated with Scottish firm Canon Medical Research Europe to develop an AI prototype for detecting pleural mesothelioma. Canon Medical specializes in medical imaging software. Pleural mesothelioma is a type of lung cancer caused by asbestos exposure. The new artificial intelligence tool is designed to find and measure mesothelioma tumors on CT scans. It can be challenging even for cancer experts to detect tiny changes in mesothelioma tumors. But the AI tool can quickly reveal how well or poorly a patient is doing on a treatment like chemotherapy. The sooner doctors know if…